Article Tools/Herramientas de artículos
+ Larger Font/Fuente más grande | - Smaller Font/Fuente más pequeña






Consumer News Popular Weight Loss Drugs Could Lower The Risk Of Certain Cancers, Study Finds

Search Related Content

Sorry, Your Requested Page Was Not Found. Greetings! We apologize for the inconvenience, but the page, Consumer News Popular Weight Loss Drugs Could Lower The Risk Of Certain Cancers, Study Finds is no longer available. Please use our search box below to find related content and browse the list of related news stories. Depending on the topic, news articles are deleted 3-18 months after their creation date. We prefer to keep content fresh and current, rather than holding onto outdated news. Thanks for visiting today.
Search RobinsPost News & Noticias


Consumer News Popular Weight Loss Drugs Could Lower The Risk Of Certain Cancers, Study Finds | RobinsPost News & Noticias

Weight-loss drugs could become unavailable for millions in coming years


The WHO issues its first official guidance on GLP-1 drugs for obesity treatment, as the disease affects over one billion people globally and is expected to double by 2030. Read More

Popular weight-loss drugs could take the edge off your alcohol buzz, study finds


Popular drugs credited with shrinking waistlines and controlling blood sugar may also take the edge off alcohol’s buzz, according to a new study. Researchers at Virginia Tech's Fralin Biomedical ... Read More

Trump strikes deal to lower cost of weight loss drugs


President Donald Trump said Thursday his administration has reached a deal to lower the cost of the blockbuster GLP-1 weight loss drugs, Wegovy and Zepbound — a move that could significantly expand ... Read More

A New Study Found That Weight-Loss Drugs Like Ozempic Could Lower Your Heart Attack Risk


A new University College London study featuring 17,604 participants age 45 and up discovered that semaglutide -- a GLP-1 agonist found in weight-loss drugs like Ozempic and Wegovy -- decreases the ... Read More

GLP-1 Weight Loss Drugs Tied to Lower Risk of Early Macular Degeneration


Preliminary studies suggest GLP-1s may offer long-term vision protection for people without diabetes, but researchers caution more research is still needed. During a 10-year study, people without ... Read More


Blow Us A Whistle


Comments (Whistles) Designed By Disqus